Guido J. Neels


Mr. Neels has served as a member of the Board of Directors since August 2015. He has been an operating partner of HW Healthcare Partners since February 2013. Guido joined HW Healthcare Partners as a partner in August 2006. From May 2004 until retiring in November 2005, he served as chief operating officer of Guidant Corporation (Guidant), a world leader in the development of cardiovascular medical products, where he was responsible for the global operations of Guidant’s four operating units—Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery and Endovascular Solutions. From December 2002 to May 2004, Guido was group chairman, office of the president at Guidant, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. From January 2000 to December 2002, he was president of Guidant for Europe, the Middle East, Africa and Canada. Guido previously served as vice president of global marketing for Vascular Intervention and as managing Director for German and Central European operations. From 1982 to 1994, until Guidant was spun off as an independent public company from Eli Lilly and Co. (Eli Lilly), he held general management, sales and marketing positions at Eli Lilly in the United States and Europe. From 1972 to 1980, he held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the United States.

Guido currently serves on the board of directors for Endologix and Bioventus. In addition to these HW Healthcare Partners portfolio companies, he also serves on the board of directors for Christel House International (a not-for-profit organization) and is an advisor for Novo Holdings in Denmark.

Guido holds a business engineering degree from the University of Leuven in Belgium and a Master of Business Administration degree from Stanford University.